Vasomotor Symptoms

Authoritative sources

• Wikidata (Q12511259)
• MeSH (D014839)
• Wikipedia

Evidence base

• Position Statement · 2022 · Landmark

  The 2022 Hormone Therapy Position Statement of The North American Menopause Society

  Menopause · The NAMS 2022 Hormone Therapy Position Statement Advisory Panel

  The most-cited modern clinical guideline: for most women in early menopause with bothersome symptoms, the benefits of HRT outweigh the risks.

• Randomized Controlled Trial · 2025

  Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

  The New England journal of medicine · Cardoso F, Parke S, Brennan DJ, Briggs P, et al.

• Randomized Controlled Trial · 2025

  Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial

  JAMA internal medicine · Panay N, Joffe H, Maki PM, Nappi RE, et al.

• Meta-Analysis · 2025

  Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis

  Obstetrics and gynecology · Menegaz de Almeida A, Oliveira P, Lopes L, Leite M, et al.

• Systematic Review · 2024

  A systematic review and critical appraisal of menopause guidelines

  BMJ sexual & reproductive health · Hemachandra C, Taylor S, Islam RM, Fooladi E, et al.

• Randomized Controlled Trial · 2023

  Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

  Obstetrics and gynecology · Neal-Perry G, Cano A, Lederman S, Nappi RE, et al.

• Randomized Controlled Trial · 2023

  Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

  Lancet (London, England) · Lederman S, Ottery FD, Cano A, Santoro N, et al.

• Systematic Review · 2023

  Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review

  Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · Alblooshi S, Taylor M, Gill N

• Randomized Controlled Trial · 2023

  Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

  The Journal of clinical endocrinology and metabolism · Johnson KA, Martin N, Nappi RE, Neal-Perry G, et al.

• Randomized Controlled Trial · 2023

  A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial

  Menopause (New York, N.Y.) · Barnard ND, Kahleova H, Holtz DN, Znayenko-Miller T, et al.

• Systematic Review · 2021

  Menopausal hormone therapy and women's health: An umbrella review

  PLoS medicine · Zhang GQ, Chen JL, Luo Y, Mathur MB, et al.

Where Vasomotor Symptoms appears on Kindr Health